EUVIMEDEUVIMED entdecken
Kontrollierte klinische Studie

Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study

Rolf Larisch, John E M Midgley, Johannes W Dietrich, Rudolf Hoermann

Nuklearmedizin - NuclearMedicine · 01.06.2024 · 63 (03) · 176-187

DOI: 10.1055/a-2240-8087 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.06.2024. Verfasst von Rolf Larisch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Nuclear Medicine, Klinikum Lüdenscheid, Lüdenscheid, Germany. Hauptthemen laut MEDLINE: Quality of Life, Hyperthyroidism, Iodine Radioisotopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioiodine treatment (RIT) has a high success rate in both the treatment of hyperthyroidism and improving the quality of life (QoL) of symptomatic patients. In asymptomatic patients with subclinical hyperthyroidism thyroid related QoL outcomes are less well known.

Methods

Study aim was to evaluate thyroid-related QoL in patients with subclinical hyperthyroidism mostly due to toxic nodular goitre undergoing RIT, compared to a control group of euthyroid subjects. Study design was monocentric, prospective, controlled. Fifty control subjects were enrolled and 51 RIT patients. Most subjects were examined at least twice at an interval of 6 months, with visits immediately before and 6 months after treatment in the RIT group. QoL was estimated with the ThyPRO questionnaire, using its composite scale as primary outcome. Treatment effect was the mean adjusted difference (MAD) between groups over time, using repeated? measures mixed? effects models.

Results

TSH concentrations were lower in the RIT group prior to treatment and recovered thereafter slightly above the level of the control group. Correspondingly, QoL improved significantly after 6 months from a worse level in the RIT group, compared to controls (MAD –10.3 [95% CI –14.9, –5.7], p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeHyperthyroidismIodine RadioisotopesHumansFemaleMaleProspective StudiesMiddle AgedTreatment OutcomeAdultRadiopharmaceuticals

Substanzen

Iodine RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Clinic of Nuclear Medicine, Klinikum Lüdenscheid, Lüdenscheid, Germany.
  • North Lakes Clinical, Ilkley LS29 8PT, United Kingdom of Great Britain and Northern Ireland.
  • Medical Hospital I, Endocrinology and Diabetes Department, Ruhr University of Bochum, Bochum, Germany.
  • Ruhr Center for Rare Diseases (CeSER), Bochum, Germany.

Zitieren

APA

Larisch, R., Midgley, J. E. M., Dietrich, J. W., & Hoermann, R. (2024). Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study. Nuklearmedizin - NuclearMedicine, 63(03), 176-187. https://doi.org/10.1055/a-2240-8087

Vancouver

Larisch R, Midgley JEM, Dietrich JW, Hoermann R. Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study. Nuklearmedizin - NuclearMedicine. 2024;63(03):176-187. doi:10.1055/a-2240-8087

BibTeX
@article{Larisch2024,
  author = {Larisch, Rolf and Midgley, John E M and Dietrich, Johannes W and Hoermann, Rudolf},
  title = {Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2024},
  volume = {63},
  number = {03},
  pages = {176--187},
  doi = {10.1055/a-2240-8087}
}
Kostenlos starten →